Krystal Biotech (KRYS) PT Raised to $255 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Alec Stranahan raised the price target on Krystal Biotech (NASDAQ: KRYS) to $255.00 (from $182.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
